MxT Biotech transforms genome editing, cancer immunotherapy, cellular engineering with our patented non-viral gene delivery platform, Hydroporator®.
Hydroporator® is an an innovative microfluidic platform for engineering cells through highly efficient gene delivery, speeding up the discovery, development, and manufacturing of novel cell and gene therapies, and beyond.
Products